Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation

Multiple sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS) that causes a whole spectrum of neurological disorders associated with a profound decrease in the quality of life of affected patients. Currently, autologous hematopoietic cell transplantation (ASCT) is a validated therapeutic approach and has been shown to be superior to new immunomodulatory agents. However, the impact of these therapies on the quality of life of patients with MS is unknown.

Source: Biology of Blood and Marrow Transplantation - January 24, 2020 Category: Hematology Authors: Juan Carlos Olivares-Gazca, Iv án Murrieta-Álvarez, Jesús Mauricio Olivares-Gazca, Yahveth Cantero-Fortiz, Yarely Itzayana García-Navarrete, Andrés Leon-Peña, Luisa Fernanda Sánchez-Valledor, Antonio Cruz-Mora, Guillermo J. Ruiz-Delgado, Guillermo Tags: 553 Source Type: research